Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» drug pricing
drug pricing
AbbVie, Novartis and more win national coverage in China even as Pfizer's Paxlovid gets left out
Fierce Pharma
Wed, 01/18/23 - 10:53 pm
AbbVie
Novartis
China
drug pricing
Pfizer
Paxlovid
AbbVie and Lilly have sent a warning signal to the UK government by leaving the voluntary medicines pricing agreement in protest over increasingly punitive revenue clawbacks
ABPI
Tue, 01/17/23 - 10:38 am
AbbVie
Eli Lilly
UK
NHS
drug pricing
California is latest state to sue drug companies over high insulin prices
Marketwatch
Thu, 01/12/23 - 09:17 pm
California
drug pricing
insulin
diabetes
legal
Eisai learns from Biogen’s Aduhelm disaster
EP Vantage
Mon, 01/9/23 - 10:35 am
Eisai
Biogen
Leqembi
Aduhelm
Alzheimer's disease
drug pricing
Eisai, in pricing new Alzheimer’s drug, tries to sidestep controversy
BioPharma Dive
Sun, 01/8/23 - 10:04 pm
Eisai
Biogen
drug pricing
Leqembi
Alzheimer's disease
lecanemab
Pharma companies boost drug prices to start year, but hikes lag inflation
BioPharma Dive
Tue, 01/3/23 - 10:39 pm
drug pricing
Mark Cuban’s Cost Plus Drug Company Continues To Revolutionize Generic Drug Pricing
Forbes
Mon, 01/2/23 - 06:28 pm
Mark Cuban
generics
drug pricing
Mark Cuban Cost Plus Drugs
Eisai and Biogen’s latest Alzheimer’s drug needs to be cheaper than the last one, analysts say
Stat
Thu, 12/22/22 - 11:10 am
Biogen
Eisai
Alzheimer's disease
drug pricing
ICER
lecanemab
Aligning drug prices with ICER estimates could save tens of billions of dollars — JAMA paper
Endpoints
Wed, 12/14/22 - 07:35 pm
ICER
Inflation Reduction Act
drug pricing
Pfizer's plan for $110+ Covid-19 vaccines riles up US senators
Endpoints
Wed, 12/14/22 - 10:23 am
Pfizer
COVID-19
vaccines
drug pricing
Senate
On its annual list of price hike offenders, ICER calls out Bausch's Xifaxan, J&J's Invega
Fierce Pharma
Wed, 12/7/22 - 10:10 am
ICER
drug pricing
Bausch Health
Xifaxan
JNJ
Invega
Despite Eye-Popping $3.5 Million Price Tag For Gene Therapy Hemgenix, Budget Impact For Most Payers Will Be Relatively Small
Forbes
Mon, 12/5/22 - 10:48 am
Hemgenix
gene therapy
hemophilia B
drug pricing
CSL
A $3.5M ‘bargain’? CSL’s hemophilia B drug sets new pricing benchmark, as gene therapy costs mount
Medical Marketing and Media
Thu, 12/1/22 - 10:34 am
CSL
Hemgenix
drug pricing
hemophila B
Sanders poised to lead Senate health committee
BioPharma Dive
Mon, 11/28/22 - 10:32 am
drug pricing
Bernie Sanders
Senate
Cost watchdog ICER backs multimillion-dollar price tags for BioMarin, CSL hemophilia gene therapies
Fierce Pharma
Thu, 11/3/22 - 11:02 am
ICER
drug pricing
gene therapy
Biomarin
CSL
Bluebird Bio
hemophilia
Sanofi, Alnylam Q3 Reports Hint at Early Pipeline Impacts from IRA
BioSpace
Mon, 10/31/22 - 04:17 pm
Sanofi
Alnylam
earnings
Inflation Reduction Act
legislation
drug pricing
Alnylam scraps trial in rare eye disorder, blaming drug price reforms
Pharmaphorum
Fri, 10/28/22 - 10:25 am
Alnylam
RNAi
vutrisiran
Stargardt disease
Inflation Reduction Act
drug pricing
ICER on MS drugs: TG's ublituximab not cost effective at the same price as Roche's ocrelizimab
Endpoints
Tue, 10/18/22 - 10:36 am
ICER
MS
multiple sclerosis
drug pricing
ublituximab
TG Therapeutics
President Biden offers another push on drug price savings via executive order
Endpoints
Sun, 10/16/22 - 05:20 pm
drug pricing
Medicare
Joe Biden
Big Pharma Says Drug Prices Reflect R&D Cos, but new study finds no correlation between research and development spending and outlandish drug prices
Wired
Fri, 10/14/22 - 10:18 am
drug pricing
R&D
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »